Certara

PRESS RELEASE

Certara Acquires d3 Medicine

Certara, a provider of decision support technology and consulting services to optimise drug development and improve health outcomes, has announced that it has acquired d3 Medicine. d3 Medicine, which is based in Parsippany, NJ, and Melbourne, Australia, provides strategic planning and stewardship of complex drug development programs.

Pages

Analysis and opinion
Feature

Robert Roe looks at research from the University of Alaska that is using HPC to change the way we look at the movement of ice sheets

Feature

Robert Roe talks to cooling experts to find out what innovation lies ahead for HPC users

Analysis and opinion